Hill-Rom Stock Analysis (NYSE:HRC)

Add to My Stocks
$73.84 $0.66 (0.9%) HRC stock closing price Apr 27, 2017 (Closing)
Watch Robo Advisor Video of HRC Stock Analysis
Hill-Rom
Updated on : Apr 27, 2017
previous close
HRC 73.8 (0%)
S&P 500 2388.8 (0%)
Closing Price On: Apr 27, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical Products
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2017-Q1
$million
%
YOY GROWTH
Compared to the industry
Long Term Growth
5 Year CAGR:
10.5%
Operating Profit
Operating Margin:
9.8%
Sector Average:
0.6%
5 Quarter Net Profit
Net Margins
2017-Q1
%
LTM Margin
Compared to the industry
Debt/Equity Ratio
Debt:
2.14B
Debt/Equity Ratio:
 1.79
Compared to the industry
Cash Flow
Operating cash flow:
$71M
Net Income:
$23.8M
Dividend Yield
HRC dividend yield:
0.92%
PROS      CONS
Operating Margins
Net Margins
Cash Flow
ROIC
ROE
FCF Margin
Long Term Growth
High Debt Burden
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
HRC PS :
1.9
Industry PS :
4.7
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
6.6%
Return on Equity:
12%
Free Cash Flow Margin:
8.3%
Double Tap To Exit Full Screen
0:00
/

Hill-Rom Analysis Video

59 5 2

View Hill-Rom stock analysis video. This is our HRC analyst opinion covering the buy and sell arguments for HRC stock.

Hill-Rom Holdings, Inc. Stock Rating (3.4/5)

Our Hill-Rom stock opinion is based on fundamentals of the company. This Hill-Rom stock analysis is based on latest Q1 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.

Should you buy HRC stock?

  • Hill-Rom had a healthy average operating margin of 9.8% over the last 4 quarters.
  • Net margins stood at a healthy 5.4% (average) for Hill-Rom in the Trailing Twelve Months.
  • The company has an operating cash flow which is 3 times the net income.
  • When compared with the Medical Products industry average PS ratio of 4.7, the price-to-sales ratio of 1.9 for HRC stock is attractive.
  • Hill-Rom has an attractive ROIC (Return on Invested Capital) of 6.6%
  • The LTM ROE of 12% for Hill-Rom is attractive.
  • The company has a healthy free cash flow margin of 8.3%.

Should you sell HRC stock?

  • Revenue growth of 10.5% has been weak over the last 5 years.
  • Hill-Rom has a debt/equity ratio of  1.79, which is worse than the average in the Medical sector.

Comments on this video and Hill-Rom stock